Synthesis, physical-chemical properties, antimicrobial and antifungal activity of some 2-(2-((5-(adamantane-1-yl)-4-R-1,2,4-triazole-3-yl)thio)acetyl)-N-R1–hydrazine-carbothioamides

Authors

  • V. M. Odyntsova Zaporizhzhia State Medical University, Ukraine,
  • A. M. Kamyshny Zaporizhzhia State Medical University, Ukraine,
  • N. N. Polischuk Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2017.3.112756

Keywords:

1, 2, 4-triazole, hydrazine-carbothioamides, IR-, NMR 1H-spectroscopy, chromatographic mass spectra, antimicrobial and antifungal activity

Abstract

Special attention of pharmaceutical scientists is attracted to the creation of new potential substances. They select natural heterocyclic molecules that exhibit various types of pharmacological activity as basic structures. Adamantane derivatives, as well as a number of other framework compounds, in the vast majority are biologically active substances. This fact causes interest to the given classes of organic compounds as potential sources for the development of new drugs. Due to the high pharmacological action of 1,2,4-triazole derivatives, the combination of adamantane and 1,2,4-triazole in one molecule can lead to the formation of high-level pharmacological substances.

The aim of this work is the synthesis of some 2- (2 - ((5- (adamantane-1-yl) -4-R-1,2,4-triasole-3-yl) thio) acetyl) -N-R1-hydrazine-carbothioamides, study of their physical and chemical properties, antimicrobial and antifungal activity.

Materials and methods. The chemical names of the compounds are given in accordance with the requirements of the IUPAC nomenclature (1979) and the recommendations of the IUPAC (1993). Study of the physical and chemical properties of 2-(2-((5-(adamantane-1-yl)-4-R-1,2,4-triazole-3-yl)thio)acetyl)-N-R1-hydrazine-carbothioamides  have been carried out on the certified and licensed equipment in the ZSMU physical-chemical laboratories. The melting temperature was determined by an open capillary method on the Opti Melt MPA 100. The elemental composition of the synthesized compounds was determined on the universal analyzer Elementar Vario L cube (CHNS) (standard – sulfanilamide). 1H NMR spectra were recorded on a spectrometer Varian Mercury VX-200 (1H, 200 MHz) in dimethylsulfoxide-d6solvent (tetramethylsilane - internal standard) and are decoded using ADVASP(tm)Analyzer program (Umatek International Inc.). Chromatographic mass spectral studies were performed on a gas-liquid chromatograph Agilent 1260 Infinity HPLC equipped with an Agilent 6120 mass spectrometer (ionization in an electric spray (ESI).

Results. New 2-(2-((5-(adamantane-1-yl)-4-R-1,2,4-triazole-3-yl)thio)acetyl)-N-R1-hydrazine-carbothioamides are firstly synthesized, their structure is established by means of modern physical chemical methods of analysis (elemental analysis, IR-, NMR 1H-spectroscopy), and their individuality is done by  HPLC-MS method. In all cases, the meanings of the investigated physical and chemical constants coincide with the estimated theoretical indicators.

Determination of antimicrobial and antifungal activity was carried out by 2-fold serial dilutions method in liquid nutrient media. As a result of conducted investigations the compounds which levels of antimicrobial and antifungal action approaching, and in some cases exceeding comparison drug trimethoprim were revealed among the synthesized compounds.

Conclusions. A compound of 2-(2-((5-(adamantane-1-yl)-4-phenyl-1,2,4-triazole-3-yl)thio)acetyl)-N-ethyl-hydrazine-carbothioamide occurred as the most active in relation to all test-strains among the synthesized substances, the force of antimicrobial and antifungal activity of it several times exceeds the comparison standard trimethoprim.

References

Kovalenko, V. N. (Ed) (2017) Kompendium. Lekarstvennye preparaty [Drugs]. Kyiv: MORION. [in Ukrainian].

Bilyi, A. K., Kovalenko, S. I., Antypenko, L. M., Kamyshnyi, O. M., & Polishchuk, N. M. (2013). Protyhrybkova ta protymikrobna aktyvnist {2-[3-heteryl-1N-1,2,4-triazol-5-il]fenil}aminiv i produktiv yikh heterotsyklizatsii [Antifungal and antimicrobial activity of {2-[3-heteryl-1H-1,2,4-triazoles-5-yl]phenyl}amine and products of their heterocyclization]. Current issues in pharmacy and medicine: science and practice, 2(12), 80–82. [in Ukrainian].

Chaudhary, P.M.,Tupe, S. G., Jorwekar, S. U., Sant, D. G., Deshpande, S. R., Maybhate, S. P., et al. (2015) Synthesis and antifungal potential of 1,2,3-triazole and 1,2,4-triazole thiol substituted strobilurin derivatives. Ind. J. Chem., 54B, 908–911.

Ebtehal Suliman Al Abdullah.(2007) Synthesis and biological testing of new 1-adamantyl derivatives: Submitted in Patrial Fulfillment of the Requirements for the Ph. D. Degreein Pharmaceutical Sciences «Pharmaceutical Chemistry» in the College of Pharmacy, King Saud University. Riyadh, Saudi Arabia.

Vrynchanu, N. O. (2010) Antymikrobni vlastyvosti novykh pokhidnykh aminoadamantanu ta eksperymentalne obhruntuvannia dotsilnosti yikh medychnoho vykorystannia (Avtoref. dis… dokt. med. nauk) [Antimicrobial properties of new amine-adamantane derivatives and experimental substantiation of their medical use expediency. Dr. med. sci. diss.]. Kyiv. [in Ukrainian].

Knysh,Ye. H., Panasenko, O. І. & Odyntsova, V. M. (patentee) (2016) Patent 113037 Ukraina, MPK C07D 249/00, A61K 31/00. Моnоеtаnоlаmоnіu 2-(3-( adamantan-1-il)-4-еtyl-1,2,4-tryazol-5-іltio)аtsеtаt, yakyi proiavliaie аktoprotektornu aktivnіst. №a201511582. [Patent Ukrainy 113037. МПК C07D 249/00, A61K 31/00. Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the active protective activity activity. №a201511582]. Biuleten, 8. [in Ukrainian].

Knysh,Ye. H., Panasenko, O. І., Odyntsova V. M. & Safonov, A. A. (patentee) (2017) Patent 113484 Ukraina, MPK C07D 249/00, A61K 31/00. Adamantan-1-amonіiu 2-((5-(adamantan-1-іl)-4-fenіl-4N-1,2,4-triazol-3-іl)tіo)atsetat, yakyi proiavliaie neiroleptychnu aktyvnіst. №a201603656 [Patent Ukrainy 113484. MPK C07D 249/00, A61K 31/00. Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the neuroleptics activity. №a201603656]. Biuleten, 2. [in Ukrainian].

Knysh,Ye. H., Panasenko, O. І., Odyntsova, V. M. & Safonov, A. A. (patentee) (2017) Patent 113483 Ukraina, MPK C07D 249/00, A61K 31/00. Adamantan-1-amoniiu 2-((5-(adamantan-1-il)-4-fenil-4N-1,2,4-tryazol-3-il)tio)atsetat, yakyi proiavliaie zharoznyzhuiuchu aktyvnist. №a201603649. [Patent Ukrainy 113483. MPK C07D 249/00, A61K 31/00. Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the antipyretic activity. №a201603649]. Biuleten, 2. [in Ukrainian].

Knysh,Ye. H., Panasenko, O. І., Odyntsova, V. M. & Safonov, A. A. (patentee) (2017) Patent 114570 Ukraina, MPK C07D 249/08, A61K 31/33. Adamantan-1-amoniiu 2-((5-(adamantan-1-il)-4-fenil-4N-1,2,4-tryazol-3-il)tio)atsetat, yakyi proiavliaie diuretychnu aktyvnist. №a201600766 [Patent Ukrainy 114570. MPK C07D 249/08, A61K 31/33. Adamantan-1-ammonium 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate that exhibits the diuretic activity. №a201600766]. Biuleten, 12. [in Ukrainian].

(2007) Nakaz MOZ Ukrainy «Pro zatverdzhennia metodychnykh vkazivok “Vyznachennia chutlyvosti mikroorhanizmiv do antybakterialnykh preparativ”» vid 5 kvitnia 2007 №167. [Order of the Ministry of Health of Ukraine About approv alguide lines «Determination of the sensitivity of microorganisms to antibiotics» from April, 5, №167]. [in Ukrainian].

Volianskyi, Yu. L., Hrytsenko, I. S., Shyrobokov, V. P., et al. (2004). Vyvchennia spetsyfichnoi aktyvnosti protymikrobnykh likarskykh zasobiv [Studying of the specific activity of antimicrobial drugs]. Kyiv. [in Ukrainian].

Downloads

How to Cite

1.
Odyntsova VM, Kamyshny AM, Polischuk NN. Synthesis, physical-chemical properties, antimicrobial and antifungal activity of some 2-(2-((5-(adamantane-1-yl)-4-R-1,2,4-triazole-3-yl)thio)acetyl)-N-R1–hydrazine-carbothioamides. Current issues in pharmacy and medicine: science and practice [Internet]. 2017Nov.1 [cited 2024Dec.24];(3). Available from: http://pharmed.zsmu.edu.ua/article/view/112756

Issue

No. 3 (2017)

Section

Synthesis of the biologically active compounds

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)